The diagnosis and treatment of HBV reactivation in immunosuppressive therapy
10.3760/cma.j.issn.1008-6706.2010.20.026
- VernacularTitle:免疫抑制治疗期间乙型肝炎病毒再激活的诊断及治疗
- Author:
Hong LIANG
- Publication Type:Journal Article
- Keywords:
HBV;
Reactivation;
Lamivudine
- From:
Chinese Journal of Primary Medicine and Pharmacy
2010;17(20):2791-2792
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore clinical curative effect of lamivudine in treatment of HBV reactivation.Methods The clinical data of HBV reactivation patients in immunosuppressive therapy were retrospectively analyzed. Results The clinical symptom and liver function recovery rate, HBV-DNA darkening rate, HBeAg darkening rate and HBe-Ag/anti HBe frequence of seroconversion of detection group were higher than that of control group,the difference was statistically significant( all P ＜ 0. 05 ). Conclusion The clinical curative effect of HBV reactivation in immunosuppressive therapy by Lamivudine was good.
